RaySearch Laboratories AB (publ) (STO:RAY.B)
209.80
+3.80 (1.84%)
At close: Jun 26, 2026
RaySearch Laboratories AB Market Cap
RaySearch Laboratories AB has a market cap or net worth of 7.19 billion as of June 26, 2026. Its market cap has decreased by -36.04% in one year.
Market Cap
7.19B
Enterprise Value
7.13B
Revenue
1.30B
Ranking
n/a
PE Ratio
32.11
Stock Price
209.80
Market Cap Chart
Since October 30, 2003, RaySearch Laboratories AB's market cap has increased from 189.23M to 7.19B, an increase of 3,700.88%. That is a compound annual growth rate of 17.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 7.19B | -7.98% |
| Dec 30, 2025 | 7.82B | 5.56% |
| Dec 30, 2024 | 7.41B | 139.20% |
| Dec 29, 2023 | 3.10B | 32.79% |
| Dec 30, 2022 | 2.33B | 20.35% |
| Dec 30, 2021 | 1.94B | -31.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 161.23B |
| Getinge AB | 53.81B |
| Sectra AB | 52.75B |
| Medicover AB | 34.73B |
| Ambea AB | 11.11B |
| Xvivo Perfusion AB | 8.15B |
| Apotea AB | 7.80B |
| MedCap AB | 7.70B |